Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation

5-HT(1A) receptors are implicated in the aetiology of schizophrenia. Herein, the influence of 15 antipsychotics on the binding of the selective 'neutral' antagonist, [3H]WAY100,635 ([3H]N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide), was examined at...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2001-10, Vol.428 (2), p.177-184
Hauptverfasser: Newman-Tancredi, A, Verrièle, L, Touzard, M, Millan, M J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 184
container_issue 2
container_start_page 177
container_title European journal of pharmacology
container_volume 428
creator Newman-Tancredi, A
Verrièle, L
Touzard, M
Millan, M J
description 5-HT(1A) receptors are implicated in the aetiology of schizophrenia. Herein, the influence of 15 antipsychotics on the binding of the selective 'neutral' antagonist, [3H]WAY100,635 ([3H]N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide), was examined at human 5-HT(1A) receptors expressed in Chinese Hamster Ovary cells. In competition binding experiments, 5-HT displayed biphasic isotherms which were shifted to the right in the presence of the G-protein uncoupling agent, GTPgammaS (100 microM). In analogy, the isotherms of ziprasidone, quetiapine and S16924 (((R-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), were displaced to the right by GTPgammaS, consistent with agonist actions. Binding of several other antipsychotics, such as ocaperidone, olanzapine and risperidone, was little influenced by GTPgammaS. Isotherms of the neuroleptics, haloperidol, chlorpromazine and thioridazine were shifted to the left in the presence of GTPgammaS, suggesting inverse agonist properties. For most ligands, the magnitude of affinity changes induced by GTPgammaS (alteration in pK(i) values) correlated well with their previously determined efficacies in [35S]GTPgammaS binding studies [Eur. J. Pharmacol. 355 (1998) 245]. In contrast, the affinity of the 'atypical' antipsychotic agent, clozapine, which is a known partial agonist at 5-HT(1A) receptors, was less influenced by GTPgammaS. When the ratio of high-/low-affinity values was plotted against efficacy, hyperbolic isotherms were obtained, consistent with a modified ternary complex model which assumes that receptors can adopt active conformations in the absence of agonist. In conclusion, modulation of [3H]-WAY100,635 binding by GTPgammaS differentiated agonist vs. inverse agonist properties of antipsychotics at 5-HT(1A) receptors. These may contribute to differing profiles of antipsychotic activity.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72225016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72225016</sourcerecordid><originalsourceid>FETCH-LOGICAL-p544-4c3bbdf122c28655c822d48d02225fc05e04236235fc5a8452e6cd919f7da8523</originalsourceid><addsrcrecordid>eNo1kN1Kw0AQhXOh2Fp9BZkrUTCwv2niXSm1FQreFEREwmZ_2pVkN2a3Qt7HBzXV9mrOwDfnHOYsGSOEWUqKohgllyF8IoR4QfhFMsI4m3JE2Tj5WRhjpZA9eAPCRduGXu58tBLEVrsYQETY7RvhgKerzR2e3UOnpW6j7wIoHXXXWKcVVD2809XH6-wNI_SQUQ6Vdcq6LYghwdnYQyei9eFxuK8PyoWdbSF60KcKxnewTNvOR20dCBnt9x94lZwbUQd9fZyTZPO02MxX6fpl-TyfrdOWM5YySatKGUyIJHnGucwJUSxXiBDCjURcI0ZoRuiwcJEzTnQmVYELM1Ui54ROktt_26HB116HWDY2SF3Xwmm_D-X0YIRwNoA3R3BfNVqVbWcb0fXl6a30F1sPczM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72225016</pqid></control><display><type>article</type><title>Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Newman-Tancredi, A ; Verrièle, L ; Touzard, M ; Millan, M J</creator><creatorcontrib>Newman-Tancredi, A ; Verrièle, L ; Touzard, M ; Millan, M J</creatorcontrib><description>5-HT(1A) receptors are implicated in the aetiology of schizophrenia. Herein, the influence of 15 antipsychotics on the binding of the selective 'neutral' antagonist, [3H]WAY100,635 ([3H]N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide), was examined at human 5-HT(1A) receptors expressed in Chinese Hamster Ovary cells. In competition binding experiments, 5-HT displayed biphasic isotherms which were shifted to the right in the presence of the G-protein uncoupling agent, GTPgammaS (100 microM). In analogy, the isotherms of ziprasidone, quetiapine and S16924 (((R-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), were displaced to the right by GTPgammaS, consistent with agonist actions. Binding of several other antipsychotics, such as ocaperidone, olanzapine and risperidone, was little influenced by GTPgammaS. Isotherms of the neuroleptics, haloperidol, chlorpromazine and thioridazine were shifted to the left in the presence of GTPgammaS, suggesting inverse agonist properties. For most ligands, the magnitude of affinity changes induced by GTPgammaS (alteration in pK(i) values) correlated well with their previously determined efficacies in [35S]GTPgammaS binding studies [Eur. J. Pharmacol. 355 (1998) 245]. In contrast, the affinity of the 'atypical' antipsychotic agent, clozapine, which is a known partial agonist at 5-HT(1A) receptors, was less influenced by GTPgammaS. When the ratio of high-/low-affinity values was plotted against efficacy, hyperbolic isotherms were obtained, consistent with a modified ternary complex model which assumes that receptors can adopt active conformations in the absence of agonist. In conclusion, modulation of [3H]-WAY100,635 binding by GTPgammaS differentiated agonist vs. inverse agonist properties of antipsychotics at 5-HT(1A) receptors. These may contribute to differing profiles of antipsychotic activity.</description><identifier>ISSN: 0014-2999</identifier><identifier>PMID: 11675034</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Animals ; Antipsychotic Agents - pharmacology ; Binding, Competitive - drug effects ; Chlorpromazine - pharmacology ; CHO Cells ; Clozapine - pharmacology ; Cricetinae ; Dose-Response Relationship, Drug ; GTP-Binding Proteins - drug effects ; GTP-Binding Proteins - metabolism ; Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology ; Haloperidol - pharmacology ; Humans ; Membranes - drug effects ; Membranes - metabolism ; Piperazines - metabolism ; Piperazines - pharmacology ; Piperidines - pharmacology ; Pyridines - metabolism ; Pyrimidinones - pharmacology ; Pyrrolidines - pharmacology ; Receptors, Serotonin - metabolism ; Receptors, Serotonin, 5-HT1 ; Thiazoles - pharmacology ; Thioridazine - pharmacology ; Tritium</subject><ispartof>European journal of pharmacology, 2001-10, Vol.428 (2), p.177-184</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11675034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Newman-Tancredi, A</creatorcontrib><creatorcontrib>Verrièle, L</creatorcontrib><creatorcontrib>Touzard, M</creatorcontrib><creatorcontrib>Millan, M J</creatorcontrib><title>Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>5-HT(1A) receptors are implicated in the aetiology of schizophrenia. Herein, the influence of 15 antipsychotics on the binding of the selective 'neutral' antagonist, [3H]WAY100,635 ([3H]N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide), was examined at human 5-HT(1A) receptors expressed in Chinese Hamster Ovary cells. In competition binding experiments, 5-HT displayed biphasic isotherms which were shifted to the right in the presence of the G-protein uncoupling agent, GTPgammaS (100 microM). In analogy, the isotherms of ziprasidone, quetiapine and S16924 (((R-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), were displaced to the right by GTPgammaS, consistent with agonist actions. Binding of several other antipsychotics, such as ocaperidone, olanzapine and risperidone, was little influenced by GTPgammaS. Isotherms of the neuroleptics, haloperidol, chlorpromazine and thioridazine were shifted to the left in the presence of GTPgammaS, suggesting inverse agonist properties. For most ligands, the magnitude of affinity changes induced by GTPgammaS (alteration in pK(i) values) correlated well with their previously determined efficacies in [35S]GTPgammaS binding studies [Eur. J. Pharmacol. 355 (1998) 245]. In contrast, the affinity of the 'atypical' antipsychotic agent, clozapine, which is a known partial agonist at 5-HT(1A) receptors, was less influenced by GTPgammaS. When the ratio of high-/low-affinity values was plotted against efficacy, hyperbolic isotherms were obtained, consistent with a modified ternary complex model which assumes that receptors can adopt active conformations in the absence of agonist. In conclusion, modulation of [3H]-WAY100,635 binding by GTPgammaS differentiated agonist vs. inverse agonist properties of antipsychotics at 5-HT(1A) receptors. These may contribute to differing profiles of antipsychotic activity.</description><subject>Animals</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Binding, Competitive - drug effects</subject><subject>Chlorpromazine - pharmacology</subject><subject>CHO Cells</subject><subject>Clozapine - pharmacology</subject><subject>Cricetinae</subject><subject>Dose-Response Relationship, Drug</subject><subject>GTP-Binding Proteins - drug effects</subject><subject>GTP-Binding Proteins - metabolism</subject><subject>Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology</subject><subject>Haloperidol - pharmacology</subject><subject>Humans</subject><subject>Membranes - drug effects</subject><subject>Membranes - metabolism</subject><subject>Piperazines - metabolism</subject><subject>Piperazines - pharmacology</subject><subject>Piperidines - pharmacology</subject><subject>Pyridines - metabolism</subject><subject>Pyrimidinones - pharmacology</subject><subject>Pyrrolidines - pharmacology</subject><subject>Receptors, Serotonin - metabolism</subject><subject>Receptors, Serotonin, 5-HT1</subject><subject>Thiazoles - pharmacology</subject><subject>Thioridazine - pharmacology</subject><subject>Tritium</subject><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kN1Kw0AQhXOh2Fp9BZkrUTCwv2niXSm1FQreFEREwmZ_2pVkN2a3Qt7HBzXV9mrOwDfnHOYsGSOEWUqKohgllyF8IoR4QfhFMsI4m3JE2Tj5WRhjpZA9eAPCRduGXu58tBLEVrsYQETY7RvhgKerzR2e3UOnpW6j7wIoHXXXWKcVVD2809XH6-wNI_SQUQ6Vdcq6LYghwdnYQyei9eFxuK8PyoWdbSF60KcKxnewTNvOR20dCBnt9x94lZwbUQd9fZyTZPO02MxX6fpl-TyfrdOWM5YySatKGUyIJHnGucwJUSxXiBDCjURcI0ZoRuiwcJEzTnQmVYELM1Ui54ROktt_26HB116HWDY2SF3Xwmm_D-X0YIRwNoA3R3BfNVqVbWcb0fXl6a30F1sPczM</recordid><startdate>20011005</startdate><enddate>20011005</enddate><creator>Newman-Tancredi, A</creator><creator>Verrièle, L</creator><creator>Touzard, M</creator><creator>Millan, M J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20011005</creationdate><title>Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation</title><author>Newman-Tancredi, A ; Verrièle, L ; Touzard, M ; Millan, M J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p544-4c3bbdf122c28655c822d48d02225fc05e04236235fc5a8452e6cd919f7da8523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Binding, Competitive - drug effects</topic><topic>Chlorpromazine - pharmacology</topic><topic>CHO Cells</topic><topic>Clozapine - pharmacology</topic><topic>Cricetinae</topic><topic>Dose-Response Relationship, Drug</topic><topic>GTP-Binding Proteins - drug effects</topic><topic>GTP-Binding Proteins - metabolism</topic><topic>Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology</topic><topic>Haloperidol - pharmacology</topic><topic>Humans</topic><topic>Membranes - drug effects</topic><topic>Membranes - metabolism</topic><topic>Piperazines - metabolism</topic><topic>Piperazines - pharmacology</topic><topic>Piperidines - pharmacology</topic><topic>Pyridines - metabolism</topic><topic>Pyrimidinones - pharmacology</topic><topic>Pyrrolidines - pharmacology</topic><topic>Receptors, Serotonin - metabolism</topic><topic>Receptors, Serotonin, 5-HT1</topic><topic>Thiazoles - pharmacology</topic><topic>Thioridazine - pharmacology</topic><topic>Tritium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Newman-Tancredi, A</creatorcontrib><creatorcontrib>Verrièle, L</creatorcontrib><creatorcontrib>Touzard, M</creatorcontrib><creatorcontrib>Millan, M J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Newman-Tancredi, A</au><au>Verrièle, L</au><au>Touzard, M</au><au>Millan, M J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2001-10-05</date><risdate>2001</risdate><volume>428</volume><issue>2</issue><spage>177</spage><epage>184</epage><pages>177-184</pages><issn>0014-2999</issn><abstract>5-HT(1A) receptors are implicated in the aetiology of schizophrenia. Herein, the influence of 15 antipsychotics on the binding of the selective 'neutral' antagonist, [3H]WAY100,635 ([3H]N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide), was examined at human 5-HT(1A) receptors expressed in Chinese Hamster Ovary cells. In competition binding experiments, 5-HT displayed biphasic isotherms which were shifted to the right in the presence of the G-protein uncoupling agent, GTPgammaS (100 microM). In analogy, the isotherms of ziprasidone, quetiapine and S16924 (((R-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), were displaced to the right by GTPgammaS, consistent with agonist actions. Binding of several other antipsychotics, such as ocaperidone, olanzapine and risperidone, was little influenced by GTPgammaS. Isotherms of the neuroleptics, haloperidol, chlorpromazine and thioridazine were shifted to the left in the presence of GTPgammaS, suggesting inverse agonist properties. For most ligands, the magnitude of affinity changes induced by GTPgammaS (alteration in pK(i) values) correlated well with their previously determined efficacies in [35S]GTPgammaS binding studies [Eur. J. Pharmacol. 355 (1998) 245]. In contrast, the affinity of the 'atypical' antipsychotic agent, clozapine, which is a known partial agonist at 5-HT(1A) receptors, was less influenced by GTPgammaS. When the ratio of high-/low-affinity values was plotted against efficacy, hyperbolic isotherms were obtained, consistent with a modified ternary complex model which assumes that receptors can adopt active conformations in the absence of agonist. In conclusion, modulation of [3H]-WAY100,635 binding by GTPgammaS differentiated agonist vs. inverse agonist properties of antipsychotics at 5-HT(1A) receptors. These may contribute to differing profiles of antipsychotic activity.</abstract><cop>Netherlands</cop><pmid>11675034</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2001-10, Vol.428 (2), p.177-184
issn 0014-2999
language eng
recordid cdi_proquest_miscellaneous_72225016
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antipsychotic Agents - pharmacology
Binding, Competitive - drug effects
Chlorpromazine - pharmacology
CHO Cells
Clozapine - pharmacology
Cricetinae
Dose-Response Relationship, Drug
GTP-Binding Proteins - drug effects
GTP-Binding Proteins - metabolism
Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology
Haloperidol - pharmacology
Humans
Membranes - drug effects
Membranes - metabolism
Piperazines - metabolism
Piperazines - pharmacology
Piperidines - pharmacology
Pyridines - metabolism
Pyrimidinones - pharmacology
Pyrrolidines - pharmacology
Receptors, Serotonin - metabolism
Receptors, Serotonin, 5-HT1
Thiazoles - pharmacology
Thioridazine - pharmacology
Tritium
title Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A23%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20antipsychotic%20agents%20at%20human%205-HT(1A)%20receptors%20determined%20by%20%5B3H%5DWAY100,635%20binding%20affinity%20ratios:%20relationship%20to%20efficacy%20for%20G-protein%20activation&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Newman-Tancredi,%20A&rft.date=2001-10-05&rft.volume=428&rft.issue=2&rft.spage=177&rft.epage=184&rft.pages=177-184&rft.issn=0014-2999&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72225016%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72225016&rft_id=info:pmid/11675034&rfr_iscdi=true